Ambu stock trades 38.15 percent below its 52-week high

Published on 09/29/2026 at 09:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambu stock stands at DKK 69.15 on September 29, 2026. UBS cut its target to DKK 72 from DKK 96, while the company repurchased 4.49 million shares.

Fotorealistische Medizintechnik-Fertigung von Einweg-Endoskopen im Reinraum — Ambu A/S (DK0060946788) zeigt fotorealistisch moderne Medizintechnik-Fertigung von Einweg-Endoskopen in steriler Reinraumumgebung, Illustration mit AI erstellt.

Ambu A/S stock (ISIN DK0060946788) was trading at DKK 69.15 on Nasdaq Copenhagen at 9:00 a.m. CEST on September 29, 2026, 38.15 percent below its 52-week high of DKK 111.80. The market value stood at DKK 18.4 billion, while the session change was -0.14 percent.

UBS cuts target to DKK 72

The most important recent analyst signal came on September 15. UBS downgraded Ambu from buy to neutral and reduced its price target from DKK 96 to DKK 72, according to MarketScreener.

The revised target is DKK 2.85 above Ambu's September 29 price, or 4.12 percent higher. UBS also projected annual sales growth of 10.3 percent for 2026 through 2030, below Ambu's stated target range of 11 percent to 13 percent, and placed its 2028 margin estimate at 15.7 percent versus Ambu's ambition of 20 percent, the report said.

Buyback adds a capital signal

Ambu completed its share buyback on September 21. According to MarketScreener, the company repurchased 4.49 million shares for DKK 300.0 million at an average price of DKK 66.78. Treasury shares then totaled 8.64 million, equal to 3.2 percent of the share capital.

The buyback average was DKK 2.37 below the September 29 market price, a 3.55 percent difference. Ambu's product mix remains centered on emergency care and resuscitation devices at 50.8 percent of sales, followed by single-use endoscopes at 30.2 percent, according to the company profile carried by MarketScreener.

Ambu stock stays above yearly low

The DKK 69.15 quote stood DKK 12.90, or 22.93 percent, above the 52-week low of DKK 56.25. Trading volume was 9,790 shares at the September 29 snapshot, giving investors a dated reference point between the stock's yearly extremes.

The company calendar lists an annual 2026 earnings release for November 4, according to MarketScreener. Until then, the contrast between the buyback average and the lower UBS target keeps valuation, execution and margin delivery central to the Ambu stock story.